The blood test measures p-tau217, which indicates the presence of amyloid and tau proteins - hallmarks of Alzheimer’s disease - in the brain.

A revolutionary blood test, set to transform how Alzheimer's disease is diagnosed, could save the NHS time and money. A clinical trial for the blood test is now welcoming its first participants, who ...